PK-V In-line Vials and Bottles CCI Tester

Pharmaceuticals

Non-Invasive, Non-Destructive, 100% in-line Integrity Inspection at high production speed.

icon-01 PLAY VIDEO

Bottles

Filled Pharmaceutical Monobloc Aerosol Cans

Vials

icon-23

Highlights

  • Autotest in real time
  • Easy to validate
  • CFR 21 part 11 compliance and 4.0 full integration
  • Quick format changeover
  • High installation flexibility
  • Automatic Drying System, no testing chamber contamination
icon-19

Technical Features

icon-12
  • Container Application: Vial and Bottles (Glass + Plastic)
  • Products: Semi-solid, Powder, Lyo, Liquid
  • Container Dimensions: Standard Vials and Bottles from 2 to 250 ml
  • Speed: Up to 600 Cpm
  • Technology: CCIT
  • Inspection features: Non-Invasive, Non-Destructive CCIT based on Vacuum & Pressure Decay Method
  • Inspection Capabilities: Microleaks detection
icon-20

Additional Benefits

icon-12

 

  • Full batch control testing: fast, reliable and repeatable
  • Testing of all nominal production line speed
  • MES (Manufacturing Execution System connection) allows remote machine data exchange & download
  • Statistical Process Control reduces deviations for a better yield control
  • Real time display of testing cycle diagrams, statistical raw data
  • Easy, quick and safe remote access
  • AHE (Automatic Head Exclusion)
  • Easy cleaning
icon-21

Technology

icon-12
  • Container Closure Integrity Testing is a non-destructive measurement technology based on the following testing methods:
    • Vacuum Decay Method
    • Pressure Decay Method
  • Measurement system comprises applying a pressure differential into an airtight testing group enclosing the container.
  • The test objective is to detect container leakages by measuring the reached pressure level as well as the pressure change over test time.
icon-22

Quality Assurance

icon-12

 

  • Equipment test method refers to:
  • Approved industry standard “ASTM F2338-09”: “Standard Test Method for Non-Destructive Detection of Leaks in Packages”
  • United States Pharmacopoeia – USP General Chapter «1207» “Packaging Integrity Evaluation”
  • EU Guidelines to GMP Medicinal Products for Human and Veterinary Use – Annex 1 “Manufacture of Sterile Medicinal Products”
  • PDA Technical Report No. 27 “Pharmaceutical Package Integrity”
  • FDA 21 CFR part 11 as well as EMA Annex 11

Learn more about this product